China Medical GatewayLoading your healthcare gateway…

BEIJING GOBROAD BOREN HOSPITAL

BEIJING GOBROAD BOREN HOSPITAL — Beijing

Hospital Profile

Beijing Gaobo Boren Hospital is the first flagship hospital established by Gaobo Medical Group in Beijing in 2017. It is a secondary general hospital and a designated hospital for Beijing medical insurance, located in the Fengtai District of Beijing, southwest of the Third Ring Road, adjacent to Jijiamiao Station on Metro Line 10. The hospital has a usable area of 14,000 square meters, specializing in the diagnosis, treatment, and research of complicated and critical diseases such as hematologic tumors, solid tumors, and brain science. It also holds qualifications for drug clinical trial institutions and a Phase I clinical trial center, aiming to build an integrated medical platform of 'clinical-research-translation.' The hospital primarily provides specialized treatment and inpatient services for hematologic diseases, pediatrics, Parkinson's disease, liver cancer, as well as outpatient and emergency services for community care. It has successively become the Beijing Diagnostic and Treatment Sub-center of Hematologic Diseases under the Institute of Hematology, Chinese Academy of Medical Sciences, a member unit of the Fengtai District Regional Medical Consortium of Beijing Tiantan Hospital, a sub-center for rare disease diagnosis and treatment of Tiantan Hospital, and has established strategic cooperation with Peking Union Medical College, Capital Medical University, Tsinghua University School of Medicine, among others. Additionally, it is a member of the Peking Union Medical College Hospital Liver Surgery Medical Consortium, a member of the Beijing You’an Hospital Medical Consortium, a blood tumor specialist training base affiliated with Beijing University of Chinese Medicine Teaching Hospital, and one of the first private hospitals in Beijing to establish an Internet hospital.

Medical Milestones

Founded in 2017; since its establishment, it has successively become part of multiple medical alliances, branch centers, and teaching bases; the hematologic oncology team has reported or presented its research results dozens of times at internationally authoritative academic conferences such as ASH, EHA, EBMT, and APBMT, with related findings published in internationally authoritative journals including British Journal of Haematology, Frontiers in Immunology, Transplantation and Cellular Therapy, and Blood Advances; since its establishment in 2017, the Hematopoietic Stem Cell Transplantation Department has completed more than 1,400 transplants.

Key Capabilities & Patient Care

Adhering to the core value of 'patient needs first,' the hospital provides high-quality medical services to patients through specialized, advanced medical diagnostic and treatment technologies, as well as professional and humane care. The hematologic oncology department has established a full-chain diagnosis and treatment system ranging from integrated diagnostics, immunotherapy, targeted therapy to hematopoietic stem cell transplantation (including CAR-T sequential therapy and combination therapy); hematopoietic stem cell transplantation covers various types and complex cases; the pediatric hematology/oncology department has improved the cure rate of childhood lymphoma to 80%-90%; the brain science department covers functional neurosurgery, movement disorders, neurodegenerative diseases, and rare disease management; liver, biliary, and thoracic oncology departments provide comprehensive treatments including minimally invasive interventions, targeted therapy, and immunotherapy. The integrated diagnostic center uses the MICM-PP model, with specimens sent from nearly 500 public hospitals nationwide. The hospital balances medical treatment with psychological, daily life, and humanistic care, collaborating with more than 30 public welfare foundations to raise tens of millions in aid funds, conducting free clinics, fundus screenings, donor registrations, and other public welfare services, and operating heartwarming programs such as caring homes, kitchens, nutritional support, psychological counseling, and ward schools.

Advanced Technology

There are 100-level operating rooms and emergency wards (including ventilators, plasma exchange, hemofiltration, and other equipment); the Department of Medical Laboratory occupies about 5,000 square meters, certified with ISO15189 and US CAP, conducting hematologic specialty tests such as cell morphology, flow cytometry, chromosome/FISH, and genetic analysis; the Department of Medical Imaging has a total investment of about 80 million yuan, equipped with Siemens 64-slice spiral CT, Siemens 3.0T MRI, PET/CT, and SPECT; it is equipped with domestically advanced HIS, LIS, and PACS information systems as well as a remote imaging consultation system; the Hematopoietic Stem Cell Transplantation Department has 19 100-level laminar flow wards, with cell collection, cryopreservation, sorting, and diagnostic laboratories. • Bed capacity: 170 open beds • Number of departments: total number not disclosed; includes Hematology/Oncology, Hematopoietic Stem Cell Transplantation, Pediatric Hematology/Oncology, Center for Innovative Oncology and Immunology, Anemia Diagnosis and Treatment Center, Liver and Biliary Tumor Precision Treatment Center, Thoracic Tumor/Immunotherapy Department, Brain Science-related departments, and laboratories, imaging, pharmacy, etc. • Number of full-time physicians: not disclosed • Multiple-site practice / specially appointed experts: exact number not disclosed; core experts verifiable: Tong Chunrong (one of the early domestic immunotherapy specialists, leading CAR-T team); hematology/oncology team results have been published multiple times at ASH, EHA, and other international conferences • Annual outpatient volume: (annual outpatient volume not disclosed) • Surgical capability: includes 100-level operating rooms and emergency wards (with ventilators, plasma exchange, hemofiltration equipment); 19 100-level laminar flow wards in the hematopoietic stem cell transplantation department; mainly non-surgical, centered on transplantation/immunotherapy • International certifications and qualifications: Department of Medical Laboratory certified with ISO15189 and US CAP; drug clinical trial institution qualification and Phase I Clinical Trial Center; designated by Beijing Medical Insurance, first batch of private internet hospitals • International services: not disclosed; nearly 500 public hospitals nationwide send tests for integrated diagnosis

International Patient Services

The hospital has provided medical services to over a hundred international patients from dozens of countries in Europe, Asia, the Americas, and Africa. It has established cooperation with insurance institutions such as Manulife, AIA, Allianz, Generali, Ping An, and Taikang to offer direct commercial insurance settlement services for patients.

Return to Home